Tissue Is Not Always the Issue: A New Era and Expanding Armamentarium of Histology-Agnostic Targeted Therapies for Solid Tumors

Get up to date on the optimal assessment of histology-agnostic biomarkers and their impact on therapeutic planning across tumor types with this comprehensive educational program featuring an on-demand webcast, downloadable slidesets, and FAQ commentary from a live expert-led symposium along with a summary clinical resource PDF to download for use in your clinic.

Share

Program Content

Activities

Histology-Agnostic Biomarker Testing in Cancer Care
Histology-Agnostic Biomarker Assessment and Impact on Cancer Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Expires: June 05, 2024

View Activity
Histology-Agnostic Biomarkers for Immunotherapy
Histology-Agnostic Biomarkers for Immunotherapy in Cancer Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Expires: June 05, 2024

View Activity
Histology-Agnostic Biomarkers for Targeted Therapy
Histology-Agnostic Biomarkers for Targeted Therapy in Cancer Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Expires: June 05, 2024

View Activity

Activities

Targeted Therapies for Solid Tumors
Tissue Is Not Always the Issue: Expanding Armamentarium of Histology-Agnostic Targeted Therapies for Solid Tumors
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2023

Expires: June 19, 2024

View Activity

Activities

Histology Agnostic FAQs
Histology-Agnostic Therapies for Solid Tumors: Experts Answer Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2023

Expires: July 30, 2024

View Activity

Activities

Histology-Agnostic Therapies
Histology-Agnostic Therapies: Clinical Pearls for Practice
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2023

View Activity

Faculty

cover img faculity

John Marshall, MD

Executive Director 
Medstar Hematology/Oncology
Director
Ruesch Center for Cure of GI Cancers
Lombardi Comprehensive Cancer Center Georgetown University
Washington, DC

cover img faculity

Nagla Abdel Karim, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
University of Virginia
Director of Early Therapeutics Program/Phase I Program
Inova Schar Cancer Institute
Fairfax, Virginia

cover img faculity

Chul Kim, MD, MPH

Associate Professor
Department of Medicine, Division of Hematology and Oncology
Georgetown Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

cover img faculity

Sapna P. Patel, MD

Chair, SWOG Melanoma Committee
SWOG Cancer Research Network
Associate Professor, Director of the Uveal Melanoma Program
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Neil H. Segal, MD, PhD

Research Director
Associate Attending, Gastrointestinal Oncology Service
Division of Gastrointestinal Oncology
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
Cornell University
New York, New York

cover img faculity

Jonathan Trent, MD, PhD

Professor of Medicine
Department of Medical Oncology
Miller School of Medicine
Sylvester Comprehensive Cancer Center
Miami, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Aadi Bioscience, Bayer HealthCare Pharmaceuticals Inc., and Lilly.

Aadi Bioscience

Bayer HealthCare Pharmaceuticals Inc.

Lilly